MSD New Zealand Committed to bringing out the best in medicinephoto
Contact Us Sitemap Worldwide
HomeProductsAbout MSDMSDNZ Press
   

Patients & Caregivers
Healthcare Professionals

Print this page
 
Welcome to MSD New Zealand


Large Number Of New Zealanders Affected By Medication Changes

New Zealanders are experiencing arguably the largest medicine switch this country has ever seen. It began on January 1 for more than 200,000  people taking the most commonly used brand of omeprazole – a heart burn medication.

From May, funding changes will also affect the 250,000  people taking the cholesterol lowering medication LIPEX® (simvastatin, MSD) although patients could be switched from as early as today.

Click here for more.

 

Our Products
> Hair Loss Treatment
www.propecia.co.nz
> Migraine Treatment
www.maxalt.co.nz
Disease Information Sites
> General Health Information
www.everybody.co.nz
> World Health Organisation
www.who.int/en/
Media
> Media
Click here for more media stories on MSD

 

About MSD
> MSD Sponsorship
MSD offers a wide range of health related sponsorship

> Science Promotion Programme
Expressing Merck's passion for innovation & science promotion

> Careers at MSD
Click here for more information on careers at MSD

Site Map Privacy Policy Terms of Use Copyright Merck & Co., Inc. (USA)